jobs

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Respiratory syncytial virus

Recent news which mentions Respiratory syncytial virus

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Tags Health care industry Pfizer Inc Merck & Co Inc
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
Tags Science Business Pharmaceuticals
From CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
Tags Science Pharmaceuticals Business
From CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
Tags Health care industry Pfizer Inc Biotech and Pharmaceuticals
From CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
Tags Science Immunizations Sanofi SA
From CNBC.com News
FDA approves Pfizer maternal RSV vaccine for infants
Tags Business Pharmaceuticals Sanofi SA
From CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
Tags Breaking news Business Pharmaceuticals
From CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
Tags Biotech and Pharmaceuticals Vaccinations Health care industry
From CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
Tags Business Pharmaceuticals Immunizations
From CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
Tags Health care industry Vaccinations Pfizer Inc
From CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
Tags Biotech and Pharmaceuticals Pfizer Inc Regulations
From CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
Tags GSK plc Respiratory syncytial virus Biotechnology
From CNBC.com News
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
Tags Health care industry Biotech and Pharmaceuticals Pfizer Inc
From CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
Tags Policy U/S/ Economy Health care industry
From CNBC.com News
Here’s what Pfizer and Moderna say is next for their Covid vaccines
Tags Biotech and Pharmaceuticals Pfizer Inc Flu
From CNBC.com News
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
Tags Science Immunizations Pharmaceuticals
From CNBC.com News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
Tags Vaccinations Health care industry Biotech and Pharmaceuticals
From CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
Tags Pfizer Inc Science Breaking news
From CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
Tags Disease outbreaks Business World News
From CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
Tags Technology Immunizations Vaccinations
From CNBC.com News
A nutritionist shares the best snacks to bring on a plane to boost your immune system
Tickers LIFE
Tags Exercise Lifestyle Entertainment
From CNBC.com News
Why flu season is so bad this year
Tickers LIFE
Tags U/S/ Economy Health care industry Policy
From CNBC.com News
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows
Tags Disease outbreaks World News Pharmaceuticals
From CNBC.com News
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
Tickers AZN AZNCF SNY
Tags REspiratory syncytial virus General AZN
From Benzinga
Pfizer's RSV Vaccine Candidate Receives FDA Breakthrough Therapy Tag For Prevention of RSV In Older Adults
Tickers PFE
Tags Benzinga Health Care Biotech
From Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
Tickers JNJ
Tags General REspiratory syncytial virus Phase 2 Trial
From Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
Tickers JNJ
Tags Phase 2 Trial Market News REspiratory syncytial virus
From Benzinga
Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients
Tickers PFE
Tags Market News General REspiratory syncytial virus
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News Instagram Instagram
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

922 Allowance Ave SE
Medicine Hat, AB T1A 3G7

Office hours: 8:30 a.m.-4:30 p.m. Monday to Friday, closed Saturday Sunday and statutory holidays.

[P] 403.527.1101
[F] 403-527-0737

Print Advertising: 403.528.5659
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2024 The Medicine Hat News